References
- Fleck R., Travis E.L. The effects of indomethacin on normal tissue radiation response. 37th Annual Meeting of the Radiation Research Society, Book of Abstracts 1989; 78–78
- Furuta Y., Hall E.R., Sanduja S., Barkley H.T., Jr, Milas L. Prostaglandin production by murine tumors as a predictor for therapeutic response to indomethacin. Cancer Research 1988a; 48: 3002–3007
- Furuta Y., Hunter N., Barkley H.T., Jr, Hall E., Milas L. Increase in radioresponse of murine tumors by treatment with indomethacin. Cancer Research 1988b; 48: 3008–3013
- Hanson W.R., Ainsworth E.J. 16-16 Dimethyl prostaglandin E2 induces radioprotection in murine intestinal and hematopoietic stem cells. Radiation Research 1985; 103: 196–203
- Milas L., Furuta Y., Hunter N., Nishiguchi I., Runkel S. Dependence of indomethacin-induced potentiation of murine tumor radioresponse on tumor host immunocompetence. Cancer Research 1990; 50: 4473–4477
- Nishiguchi I., Furuta Y., Hunter N., Murray D., Milas L. Radioprotection of hematopoietic tissues in mice by indomethacin. Radiation Research 1990; 122: 188–192
- Runkel, S., Hunter, N., Milas, L. An intradermal assay for quantitation and kinetics studies of tumor angiogenesis in mice. Radiation Research, In press, 1991
- Walden T.L., Jr, Patchen M., Synder S.L. 16,16-Dimethyl prostaglandin E2 increases survival in mice following irradiation. Radiation Research 1987; 109: 440–448
- Ziche M., Jones S., Gullino P.M. Role of prostaglandin E1 and copper in angiogenesis. Journal of the National Cancer Institute 1982; 69: 475–481